Novocure Has Sponsored Pulitzer Prize-winning Author Dr. Siddhartha Mukherjee As The Keynote Speaker Of 21st Annual Scientific Meeting Of The Society For Neuro-Oncology On Nov. 19, 2016, In Scottsdale, Arizona. (Photo: Business Wire)
Novocure (NASDAQ:NVCR) announced today that it has sponsored Pulitzer Prize-winning author Dr. Siddhartha Mukherjee as the keynote speaker of the 21 st Annual Scientific Meeting of the Society for Neuro-Oncology on Nov. 19, 2016, in Scottsdale, Arizona. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161114005480/en/
Novocure has sponsored Pulitzer Prize-winning author Dr. Siddhartha Mukherjee as the keynote speaker of 21st Annual Scientific Meeting of the Society for Neuro-Oncology on Nov. 19, 2016, in Scottsdale, Arizona. (Photo: Business Wire)
"I am deeply honored to deliver a talk at the Society for Neuro-Oncology meeting," Dr. Mukherjee said. "The prevention, treatment and cure of brain cancers remain a major scientific challenge, although new medical breakthroughs are changing the landscape for patients. The society's meeting will highlight these important breakthroughs and focus attention on these important cancers." Dr. Mukherjee, a physician and researcher, wrote the Pulitzer Prize-winning and New York Times bestselling book The Emperor of All Maladies, a biography of cancer, which chronicles the disease. In 2015, PBS premiered a documentary from Ken Burns based on Dr. Mukherjee's book. Dr. Mukherjee's follow-up, bestselling book, The Gene: An Intimate History - published in 2016 - tells "the story of the quest to decipher the master-code of instructions that makes and defines humans, that governs our form, function, and fate and determines the future of our children." "We are honored to support Dr. Mukherjee's keynote address during the SNO annual meeting and commend his important work as a cancer researcher, physician and author who has educated many on the story of cancer," said Bill Doyle, Novocure's Executive Chairman. "We believe Novocure is an innovator in cancer treatment and an important contributor to the evolution of cancer care moving forward."